MyFinsight
Home
Blog
About
Contact
Proceeds from issuance of
common stock, net of...
$706K
Proceeds from loan
payable
$327K
Net cash provided by
financing activities
$952K
Canceled cashflow
$81K
Net decrease in cash
and cash...
-$3,412K
Canceled cashflow
$952K
Stock-based compensation
expense
$694K
Prepaid expenses
-$435K
Amortization of operating
lease right-of-use...
$171K
Depreciation expense
$66K
Repayments of loan payable
$81K
Net cash used in
operating activities
-$4,364K
Canceled cashflow
$1,366K
Net loss
-$5,000K
Other current assets
$403K
Operating lease liability
-$178K
Accounts payable and
accrued expenses
-$95K
Change in fair value of
sepa put option...
$54K
Back
Back
Cash Flow
source: myfinsight.com
FibroBiologics, Inc. (FBLG)
FibroBiologics, Inc. (FBLG)